Please Wait...

LitTrace

Literature Monitoring Tool

LitTrace is a customizable literature monitoring and tracking tool that ensures timely access to reliable and consolidated information on relevant safety-related literature and creates databases for ICSR's and similar compliance reports.

LitTrace can be used to monitor literature relating to:

  • Clinical evaluation
  • Pre-market approval
  • Adverse events reporting

Benefits of LitTrace include:

  • Fully customizable – per client's unique requirements
  • Flexible folder structure – build multiple folders based on product or therapeutics areas (including subfolders)
  • Import third party data – EMBASE, MEDLINE, etc.
  • Simple, easy-to-use tool – for assessment workflow tracking
  • Configurable reporting engine
  • Flexible delivery options – client environment or Bioclinica hosted
  • Central repository – for weekly hits and full-text articles
  • One-stop solution to track full-text article – translation and contract author requests preparation and compliance as required by the FDA, EMEA and other global regulatory bodies

Download our info sheet

ADDITIONAL RESOURCES

LitTrace and PVTrace

Download Info Sheet

Meet the Bioclinica Safety and Regulatory Team: Sukrit Singh, Engagement Manager

Read Blog

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (42 minutes ago)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (52 minutes ago)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (54 minutes ago)
RT @bioclinica: Keeping to timelines in #clinicaltrials is key but can be hard to achieve. Join Bioclinica's Justin Hunt a webinar Nov. 2…
bioclinica (57 minutes ago)
RT @Xtalks: Removing Risk from #ClinicalTrial Management System (CTMS) Implementations @bioclinica https://t.co/EfuSVMSL13
bioclinica (7 hours ago)
Our Research Dev. Director Marieke Cajal in a poster presentation at #CNS Summit showed, "How to Scale up Recruitme… https://t.co/ySQpGIjvt9
bioclinica (7 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices